Search Results - "Mathis, Chester A"

Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein.

Authors: Varlow, Cassis Pees, Anna Stehouwer, Jeffrey S et al.

Source: Journal of Parkinson's Disease. Jun2026, Vol. 16 Issue 4, p683-698. 16p.

First-in-human PET neuroimaging of [¹⁸F]OXD-2314.

Authors: Murrell, Emily Narciso, Lucas Desmond, Kimberly L. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2025, Vol. 53 Issue 1, p410-415. 6p.

Objective Assessment of Cognition for Detecting Subjective Cognitive Decline Is More Accurate than Subjective Estimations: The Role of Trait Affect.

Authors: Frantzi, Nikoleta Moraitou, Despina Emmanouilidou, Eudokia et al.

Source: Journal of Intelligence. Sep2025, Vol. 13 Issue 9, p118. 17p.

Discovery of N -(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson's Disease with Positron Emission Tomography.

Authors: Zhao, Haiyang Huang, Tianyu Dhavale, Dhruva D. et al.

Source: Cells (2073-4409). Jul2025, Vol. 14 Issue 14, p1108. 23p.

Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein.

Authors: Pees, Anna Tong, Junchao Birudaraju, Saritha et al.

Source: Chemistry - A European Journal; Apr2024, Vol. 30 Issue 23, p1-14, 14p

11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous.

Authors: Abrahamson, Eric E Kofler, Julia K Becker, Carl R et al.

Source: Brain: A Journal of Neurology; Jun2022, Vol. 145 Issue 6, p2161-2176, 16p

Serotonin transporter binding after recovery from eating disorders.

Authors: Bailer, Ursula F. Frank, Guido K. Henry, Shannan E. et al.

Source: Psychopharmacology. Dec2007, Vol. 195 Issue 3, p315-324.

Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa.

Authors: Bailer, Ursula F. Narendran, Rajesh Frankle, W. Gordon et al.

Source: International Journal of Eating Disorders. Mar2012, Vol. 45 Issue 2, p263-271. 9p. 2 Charts, 2 Graphs.

Subjects: Amphetamines, Analysis of variance, Anorexia nervosa, Anxiety, Comparative studies, Dopamine, Research funding, Self-evaluation, Statistical hypothesis testing, T-test (Statistics), Positron emission tomography, Effect sizes (Statistics), Body mass index, Visual analog scale, Continuing education units, Repeated measures design, Pharmacodynamics

5-HT1A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors: Bailer, Ursula F. Bloss, Cinnamon S. Frank, Guido K. et al.

Source: International Journal of Eating Disorders. Sep2011, Vol. 44 Issue 6, p477-487. 11p. 3 Charts, 2 Graphs.

Subjects: Blood testing, Analysis of variance, Anxiety testing, Bulimia, Comparative studies, Convalescence, Interviewing, Magnetic resonance imaging, Regression analysis, Self-report inventories, Statistics, Positron emission tomography, Serotonin agonists, Sample size (Statistics), Data analysis, Repeated measures design, Data analysis software

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.

Authors: Villemagne, Victor Klunk, William Mathis, Chester et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2012, Vol. 39 Issue 2, p209-219. 11p. 1 Color Photograph, 2 Graphs.

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease.

Authors: Amadoru, Sanka Doré, Vincent McLean, Catriona A. et al.

Source: Alzheimer's Research & Therapy. 3/4/2020, Vol. 12 Issue 1, p1-8. 8p.

Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials.

Authors: Cui, Chendi Birru, Rahel L Snitz, Beth E et al.

Source: Nutrition Reviews. Feb2020, Vol. 78 Issue 2, p134-144.

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.

Authors: Klein, Gregory Delmar, Paul Voyle, Nicola et al.

Source: Alzheimer's Research & Therapy. 12/12/2019, Vol. 11 Issue 1, p1-12. 12p.

Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Authors: Tosun D Schuff N Mathis CA et al.

Source: Brain: A Journal of Neurology; Apr2011, Vol. 134 Issue 4, p1077-1088, 12p

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Authors: Ikonomovic MD Klunk WE Abrahamson EE et al.

Source: Brain: A Journal of Neurology; Jun2008, Vol. 131 Issue 6, p1630-1645, 16p

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors: Pike KE Savage G Villemagne VL et al.

Source: Brain: A Journal of Neurology; Nov2007, Vol. 130 Issue 11, p2837-2844, 8p

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation.

Authors: Price, Julie C. Mathis, Chester A. Klunk, William E.

Source: Journal of Translational Medicine. 2012, Vol. 10 Issue Suppl 2, pA31-A31. 2p.

Quantification of 5-HT1A and 5-HT2A receptor Binding in Depressed Suicide Attempters and Non-Attempters.

Authors: Mann, J. John Metts, Allison V. Ogden, R. Todd et al.

Source: Archives of Suicide Research. Jan-Mar2019, Vol. 23 Issue 1, p122-133. 12p.

Functional brain network dynamics based on the Hindmarsh–Rose model.

Authors: Lv, Guiyang Zhang, Nayue Ma, Kexin et al.

Source: Nonlinear Dynamics. Apr2021, Vol. 104 Issue 2, p1475-1489. 15p.

Direct comparison of the tau PET tracers [18F]flortaucipir and [18F]MK-6240 in human subjects.

Authors: Gogola, Alexandra Minhas, Davneet S. Villemagne, Victor L. et al.

Source: Journal of Nuclear Medicine. Dec2021, Vol. 62 Issue 12, Preceding p1-31. 38p.